Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease
- 1 May 2000
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 15 (3), 552-560
- https://doi.org/10.1002/1531-8257(200005)15:3<552::aid-mds1020>3.0.co;2-p
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Experimental Therapeutics of Neurodegenerative Disorders: Unmet NeedsScience, 1998
- Unified Huntington's disease rating scale: A follow upMovement Disorders, 1998
- Does CAG repeat number predict the rate of pathological changes in Huntington's disease?Annals of Neurology, 1998
- [11C]Raclopride‐PET studies of the Huntington's disease rate of progression: Relevance of the trinucleotide repeat lengthAnnals of Neurology, 1998
- Functional decline in Huntington's diseaseMovement Disorders, 1995
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993
- Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's diseaseAnnals of Neurology, 1992
- Huntington's disease in venezuela: 7 years of follow‐up on symptomatic and asymptomatic individualsMovement Disorders, 1990
- A controlled clinical trial of baclofen as protective therapy in early huntington's diseaseAnnals of Neurology, 1989
- Reduced Cerebral Glucose Metabolism in Asymptomatic Subjects at Risk for Huntington's DiseaseNew England Journal of Medicine, 1987